nach oben

Erschienen in:

13.12.2023 | Original Communication

Peering further into the mind’s eye: combining visual evoked potential and optical coherence tomography measures enhances insight into the variance in cognitive functioning in multiple sclerosis

verfasst von: Thomas J. Covey, Daniel Golan, Robert Sergott, Jeffrey Wilken, Myassar Zarif, Barbara Bumstead, MariJean Buhse, Olivia Kaczmarek, Glen M. Doniger, Iris-Katharina Penner, Laura M. Hancock, Hans Bogaardt, Marissa A. Barrera, Sarah A. Morrow, Steve Galetta, Mark Gudesblatt

Erschienen in: Journal of Neurology | Ausgabe 2/2024

Einloggen, um Zugang zu erhalten

Abstract

Background

Spectral Optical Coherence Tomography (OCT) and Visual Evoked Potentials (VEPs) have both emerged as potentially useful biomarkers of cognitive decline in people with multiple sclerosis (PwMS). Their combined use may provide additional predictive value for identifying disease impact, progression, and remyelination capacity above-and-beyond what is captured using either approach alone.

Objective

We examined the relationship between OCT/VEP measures and cognitive functioning in 205 PwMS. OCT measures included Retinal Nerve Fiber Layer Volume (RNFLV), Papillo-Macular Bundle Volume (PBMV), and Macular Volume (MV). VEP measures included latency of the P100, and inter-ocular latency. Cognitive performance was evaluated across seven separate domains of performance, and for overall cognition, using the NeuroTrax computerized testing battery.

Results

Both OCT and VEP measures were significantly correlated with cognitive performance across several domains. Linear regression models that controlled for the influence of visual acuity revealed (1) that reduced MV was significantly predictive of poorer visual-spatial functioning, and (2) that delayed VEP latency was significantly predictive of performance in global cognitive functioning and visual-spatial functioning, after controlling for multiple comparisons. Among PwMS with normal visual acuity, PwMS with a combination of both relatively low MV and delayed VEP latency tended to have poorer performance in the domains of global, executive, and visual-spatial functioning compared to PwMS with both high MV and normal VEP latency.

Conclusion

Approaches that combine the use of OCT and VEP measures can enhance insight into underlying factors that contribute to variance in cognitive functioning in PwMS.

Nur mit Berechtigung zugänglich

Backner Y, Petrou P, Glick-Shames H, Raz N, Zimmermann H, Jost R, Scheel M, Friedemann P, Karussis D, Levin N (2019) Vision and vision-related measures in progressive multiple sclerosis. Front Neurol 10:455. https://doi.org/10.3389/fneur.2019.00455CrossRefPubMedCentralPubMed

Barton JL, Garber JY, Klistorner A, Barnett MH (2019) The electrophysiological assessment of visual function in Multiple Sclerosis. Clin Neurophysiol Pract 4:90–96. https://doi.org/10.1016/j.cnp.2019.03.002CrossRefPubMedCentralPubMed

Hardemeier M, Fuhr P (2021) Multimodal evoked potentials as candidate prognostic and response biomarkers in clinical trials of multiple sclerosis. J Clin Neurophysiol 38:171–180. https://doi.org/10.1097/wnp.0000000000000723CrossRef

Kolappan M, Henderson APD, Jenkins TM, Wheeler-Kingshott CAM, Plant, GT…Miller. (2009) Assessing structure and function of the afferent visual pathway in multiple sclerosis and associated optic neuritis. J Neurol 256:305–319. https://doi.org/10.1007/s00415-009-0123-zCrossRefPubMed

Sakai RE, Feller DJ, Galetta KM, Galetta SL, Balcer LJ (2011) Vision in multiple sclerosis (MS): the story, structure-function correlations, and models for neuroprotection. J Neuroophthalmol 31(4):362–373. https://doi.org/10.1097/wno.0b013e318238937fCrossRefPubMedCentralPubMed

You Y, Klistorner A, Thie J, Graham SL (2011) Latency delay of visual evoked potential is a real measurement of demyelination in a rat model of optic neuritis. Investig Ophthalmol Vis Sci 52(9):6911. https://doi.org/10.1167/iovs.11-7434CrossRef

Mowry EM, Loguidice MJ, Daniels AB, Markowitz CE, Galetta SL, Nano-Schiavi, ML…Balcer. (2009) Vision related quality of life in multiple sclerosis: correlation with new measures of low and high contrast letter acuity. J Neurol Neurosurg Psychiatry 80:767–772. https://doi.org/10.1136/jnnp.2008.165449CrossRefPubMed

Heesen C, Böhm J, Reich C, Kasper J, Goebel M, Gold SM (2008) Patient perception of bodily functions in multiple sclerosis: gait and visual function are the most valuable. Mult Scler 14:988–991. https://doi.org/10.1177/1352458508088916CrossRefPubMed

Cellina M, Floridi C, Rosti C, Orsi M, Panzeri M, Pirovano, M…Giballi. (2019) MRI of acute optic neuritis (ON) at the first episode: Can we predict the visual outcome and the development of multiple sclerosis (MS)? La radiologica medica 124:1296–1303CrossRef

10.

https://doi.org/10.1007/s11547-019-01073-1

11.

Osborne BJ, Volpe NJ (2009) Optic neuritis and risk of MS: Differential diagnosis and management. Clevel Clin J Med 76(3):181–190. https://doi.org/10.3949/ccjm.76a.07268CrossRef

12.

Petrillo J, Balcer L, Galetta S, Chai Y, Xu L, Cadavid D (2019) Initial impairment and recovery of vision-related functioning in participants with acute optic neuritis form the RENEW trial of Opicinumab. Journal of Neuroopthalmol 39(2):153–160. https://doi.org/10.1097/wno.0000000000000697CrossRef

13.

Rothman A, Murphy OC, Fitzgerald KC, Button J, Gordon-Lipkin, E…Calabresi. (2019) Retinal measurements predict 10-year disability in multiple sclerosis. Annals of Clinical and Translational Neurology 6(2):222–232. https://doi.org/10.1002/acn3.674CrossRefPubMedCentralPubMed

14.

Sepulcre J, Murie-Fernandez M, Salinas-Alaman A, García-Layana A, Bajarano B, Villoslada P (2007) Diagnostic accuracy of retinal abnormalities in predicting disease activity in MS. Neurology 68(18):1488–1494. https://doi.org/10.1212/01.wnl.0000260612.51849.edCrossRefPubMed

15.

Alshowaeir D, Yiannikas C, Garrick R, Parratt J, Barnett MH, Graham SL, Klistorner A (2014) Latency of multifocal visual evoked potentials in nonoptic neuritis eyes of multiple sclerosis patients associated with optic radiation lesions. Investig Ophtalmol Vis Sci 55(6):3758–3764. https://doi.org/10.1167/iovs.14-14571CrossRef

16.

Klistorner, A, Vootakuru, N, Wang, C, Yiannikas, C, Graham, SL, Parratt, J…Barnett. 2015. Decoding diffusivity in multiple sclerosis: Analysis of optic radiation lesional and non-lesional white matter. PLoS ONE, 10(3), e0122114. https://doi.org/10.1371/2Fjournal.pone.0122114

17.

Kolbe, SC, van der Walt, A, Butzkueven, H, Klistorner, A, Egan, GF, Kilpatrick, TJ. 2016. Serial diffusion tensor imaging of the optic radiations after acute optic neuritis. J Ophthalmol, 2764538. https://doi.org/10.1155/2016/2764538

18.

Gabilondo I, Rilo O, Ojeda N, Pena J, Gómez-Gastiosoro A, Bilbao M, M…Ibarretxe-Bilbao. (2016) The influence of posterior visual pathway damage on visual information processing speed in multiple sclerosis. Mult Scler J 23(9):1276–1288. https://doi.org/10.1177/1352458516676642CrossRef

19.

Grazioli E, Zivadinov R, Weinstock-Guttman B, Lincoff N, Baier M, Wong, JR…Ramanathan. (2008) Retinal nerve fiber layer thickness is associated with brain MRI outcomes in multiple sclerosis. Journal of Neurological Sciences 268:12–17. https://doi.org/10.1212/01.wnl.0000295995.46586.aeCrossRef

20.

Kuo AN, Verkicharla PK, McNabb RP, Cheung CY, Hilal S, Farsiu, S…Izatt, JA. (2015) Posterior eye chape measurement with retinal OCT compared to MRI. Invest Ophthalmol Vis Sci 57:196–203. https://doi.org/10.1167/iovs.15-18886CrossRef

21.

Sotirchos ES, Saidha S (2018) OCT is an alternative to MRI for monitoring MS – YES. Mult Scler J 24(6):701–703. https://doi.org/10.1177/1352458517753722CrossRef

22.

Jakimovski D, Benedict RHB, Weinstock-Guttman B, Ozel O, Fuchs TA, Lincoff, N…Zivadinov. (2021) Visual deficits and cognitive assessment of multiple sclerosis: Confounder, correlate, or both? J Neurol 268:2578–2588. https://doi.org/10.1007/s00415-021-10437-5CrossRefPubMed

23.

Leocani L, Guerrieri S, Comi G (2018) Visual evoked potentials as a biomarker in multiple sclerosis and associated optic neuritis. J Neuroophthalmol 38:350–357. https://doi.org/10.1097/wno.0000000000000704CrossRefPubMed

24.

Covey TJ, Golan D, Zarif M, Bumstead B, Buhse M, Kaczmarek, O…Gudesblatt. (2022) Individual differences in visual evoked potential latency are associated with variance in brain tissue volume in people with multiple sclerosis: An analysis of brain function-structure correlates. Multiple Sclerosis and Related Disorders 68:104116. https://doi.org/10.1016/j.msard.2022.104116CrossRefPubMed

25.

Weinstock-Guttman B, Baier M, Stockton R, Weinstock A, Justinger T, Munschauer, F…Rudick. (2003) Pattern reversal visual evoked potentials as a measure of visual pathway pathology in multiple sclerosis. Mult Scler 9(5):529–534. https://doi.org/10.1191/1352458503ms935rrCrossRefPubMed

26.

Covey TJ, Golan D, Doniger GM, Sergott R, Zarif M, Srinivasan…Gudesblat. (2021) Visual evoked potential latency predicts cognitive function in people with multiple sclerosis. J Neurol 268(11):4311–4320. https://doi.org/10.1007/s00415-021-10561-2CrossRefPubMed

27.

Covey TJ, Golan D, Doniger GM, Sergott R, Zariff M, Bumstead, B…Gudesblatt. (2022) Longitudinal assessment of the relationship between visual evoked potentials and cognitive performance in multiple sclerosis. Clin Neurophysiol 137:66–74. https://doi.org/10.1016/j.clinph.2022.02.013CrossRefPubMed

28.

Covey TJ, Golan D, Doniger GM, Sergott R, Zarif M, Bumstead, B…Gudesblatt. (2022) The relationship between cognitive impairment, cognitive fatigue, and visual evoked potential latency in multiple sclerosis. Multiple Sclerosis and Related Disorders 57:103349. https://doi.org/10.1016/j.msard.2021.103349CrossRefPubMed

29.

Covey TJ, Golan D, Doniger GM, Sergott R, Zarif M, Bumstead, B…Gudesblatt. (2022) Prolonged visual evoked potential latency predicts longitudinal worsening of fatigue in people with multiple sclerosis. Multiple Sclerosis and Related Disorders 67:104073. https://doi.org/10.1016/j.msard.2022.104073CrossRefPubMed

30.

Clemens L, Langdon D (2018) How does cognition relate to employment in multiple sclerosis? A systematic review. Multiple Sclerosis and Related Disorders 26:183–191. https://doi.org/10.1016/j.msard.2018.09.018CrossRefPubMed

31.

Gullo HL, Fleming J, Bennett S, Shum DHK (2019) Cognitive and physical fatigue are associated with distinct problems in daily functioning, role fulfilment, and quality of life in multiple sclerosis. Multiple Sclerosis and Related Disorders 31:118–123. https://doi.org/10.1016/j.msard.2019.03.024CrossRefPubMed

32.

Johnen A, Landmeyer NC, Bürkner P-C, Wiendl H, Meuth SG, Holling H (2017) Distinct cognitive impairments in different disease courses of multiple sclerosis – A systematic review and meta-analysis. Neurosci Biobehav Rev 83:568–578. https://doi.org/10.1016/j.neubiorev.2017.09.005CrossRefPubMed

33.

Shevil E, Finlayson M (2009) Process evaluation of a self-management cognitive program for persons with multiple sclerosis. Patient Educ Couns 76(1):77–83. https://doi.org/10.1016/j.pec.2008.11.007CrossRefPubMed

34.

Bogaardt H, Golan D, Barrera MA, Attrill S, Kaczmarek O, Zarif, M…Gudesblatt. (2023) Cognitive impairment, fatigue and depression in multiple sclerosis: Is there a difference between benign and non-benign MS? Multiple Sclerosis and Related Disorders 73:104630. https://doi.org/10.1016/j.msard.2023.104630CrossRefPubMed

35.

Leach JM, Cutter G, Golan D, Doniger G, Zarif M, Bumstead, B…Gudesblatt. (2022) Measuring cognitive function by the SDMT across functional domains: Useful but not sufficient. Multiple Sclerosis and Related Disorders 60:103704. https://doi.org/10.1016/j.msard.2022.103704CrossRefPubMed

36.

Eklund A, Huang-Link Y, Kovácsovics B, Dahle C, Vrethem M, Lind J (2022) OCT and VEP correlate to disability in secondary progressive multiple sclerosis. Multiple Sclerosis and Related Disorders 68:104255. https://doi.org/10.1016/j.msard.2022.104255CrossRefPubMed

37.

Bizzo BC, Arruda-Sanchez T, Tobyne SM, Birely JD, Lev MH, Gasparetto EL, Klawiter EC (2020) Anterior insular resting-state functional connectivity is related to cognitive reserve in multiple sclerosis. J Neuroimaging 31(1):98–102. https://doi.org/10.1111/jon.12779CrossRefPubMed

38.

Cooray GK, Sundgren M, Brismar T (2020) Mechanism of visual network dysfunction in relapsing-remitting multiple sclerosis and its relation to cognition. Clin Neurophysiol 131:361–367. https://doi.org/10.1016/j.clinph.2019.10.029CrossRefPubMed

39.

Zaccagna F, Matys T, Massoud TF (2019) Optic chiasm morphometry changes in multiple sclerosis: feasibility of a simplified brain magnetic resonance imaging measure of white matter atrophy. Clin Anat 32(8):1072–1081. https://doi.org/10.1002/ca.23446CrossRefPubMed

40.

Baetge SJ, Dietrich M, Filser M, Renner A, Stute N, Gasis, M…Penner. (2021) Association of retinal layer thickness with cognition in patients with multiple sclerosis. Neurol Neuroimmunol Neuroinflamm 8:e1018. https://doi.org/10.1212/NXI.0000000000001018CrossRefPubMedCentralPubMed

41.

Birkeldh U, Manouchehrinia A, Hietala MA, Hillert J, Olsson T, Piehl, F…Nilsson. (2017) The temporal retinal nerve fiber layer thickness is the most important optical coherence tomography estimate in multiple sclerosis. Front Neurol 8:675. https://doi.org/10.3389/2Ffneur.2017.00675CrossRefPubMedCentralPubMed

42.

Bsteh G, Hegen H, Teuchner B, Amprosi M, Berek K, Ladstätter, F…Berger. (2017) Peripapillary retinal nerve fibre layer as measured by optical coherence tomography is a prognostic biomarker not only for physical but also for cognitive disability progression in multiple sclerosis. Mult Scler J 25(2):196–203. https://doi.org/10.1177/1352458517740216CrossRef

43.

Achiron A, Doniger GM, Harel Y, Appleboim-Gavish N, Lavie M, Simon ES (2007) Prolonged response times characterize cognitive performance in multiple sclerosis. Eur J Neurol 14(10):1102–1103. https://doi.org/10.1111/j.1468-1331.2007.01909.xCrossRefPubMed

44.

Golan D, Wilken J, Doniger GM, Fratto T, Kane R, Srinivasan, J…Gudesblatt. (2019) Validity of a multi-domain computerized cognitive assessment battery for patients with multiple sclerosis. Multiple Sclerosis and Related Disorders 30:154–162. https://doi.org/10.1016/j.msard.2019.01.051CrossRefPubMed

45.

Thompson AJ, Banwell BL, Barkhof F, Carroll WM, Coetzee T, Comi, G…Cohen. (2018) Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol 17(2):162–173. https://doi.org/10.1016/s1474-4422(17)30470-2CrossRefPubMed

46.

American Clinical Neurophysiology Society (2006) Guideline 9B: guidelines on visual evoked potentials. J Clin Neurophysiol 23(2):138–156CrossRef

47.

Gao LY, Liu Y, Li XH, Bai QH, Liu P (2015) Abnormal retinal nerve fiber layer thickness and macula lutea in patients with mild cognitive impairment and Alzheimer’s disease. Arch Gerontol Geriatr 60:162–167. https://doi.org/10.1016/j.archger.2014.10.011CrossRefPubMed

48.

Ge Y-J, Xu W, Ou Y-N, Qu Y, Ma Y-H, Huang, Y-Y…Yu. (2021) Retinal biomarkers in Alzheimer’s disease and mild cognitive impairment: A systematic review and meta-analysis. Ageing Res Rev 69:101361. https://doi.org/10.1016/j.arr.2021.101361CrossRefPubMed

49.

Iseri PK, Altinas Ö, Tokay T, Yüksel N (2006) Relationship between cognitive impairment and retinal morphological and visual functional abnormalities in Alzheimer’s Disease. J Neuro-Ophthalmol 26:18–24. https://doi.org/10.1097/01.wno.0000204645.56873.26CrossRef

50.

Noah AM, Almghairbi D, Moppett IK (2020) Optical coherence tomography in mild cognitive impairment – Systematic review and meta-analysis. Clin Neurol Neurosurg 196:106036. https://doi.org/10.1016/j.clineuro.2020.106036CrossRefPubMed

51.

Sánchez D, Castilla-Marti M, Marquié M, Valero S, Moreno-Grau S, Rodríguez-Gómez, O…Ruiz. (2020) Evaluation of macular thickness and volume tested by optical coherence tomography as biomarkers for Alzheimer’s disease in a memory clinic. Sci Rep 10:1580. https://doi.org/10.1038/s41598-020-58399-4CrossRefPubMedCentralPubMed

52.

Mejia-Vergara A, Restrepo-Jimenez P, Pelak VS (2020) Optical coherence tomography in mild cognitive impairment: A systematic review and meta-analysis. Front Neurol 11:578698. https://doi.org/10.1016/j.clineuro.2020.106036CrossRefPubMedCentralPubMed

53.

Alonso R, Gonzalez-Moron D, Garcea O (2018) Optical coherence tomography as a biomarker of neurodegeneration in multiple sclerosis: A review. Multiple Sclerosis and Related Disorders 22:77–82. https://doi.org/10.1016/j.msard.2018.03.007CrossRefPubMed

54.

Bsteh G, Berek K, Hegen H, Altmann P, Wurth S, Auer, M…Berger. (2021) Macular ganglion cell-inner plexiform layer thinning as a biomarker of disability progression in relapsing multiple sclerosis. Mult Scler J 27(5):684–694. https://doi.org/10.1177/1352458520935724CrossRef

55.

Petracca M, Sumowski J, Fabian M, Miller A, Lublin F, Inglese M (2018) Looking into cognitive impairment in primary-progressive multiple sclerosis. Eur J Neurol 25:192–195. https://doi.org/10.1111/ene.13489CrossRefPubMed

56.

Saidha S, Al-Louzi O, Ratchford JN, Bhargava P, Oh J, Newsome, SD…Calabresi. (2015) Optical coherence tomography reflects brain atrophy in multiple sclerosis: A four-year study. Ann Neurol 78:801–813. https://doi.org/10.1002/ana.24487CrossRefPubMedCentralPubMed

57.

Coric D, Balk LJ, Verrijp M, Eijlers A, Schoonheim MM, Killestein…Petzold. (2018) Cognitive impairment in patients with multiple sclerosis is associated with atrophy of the inner retinal layers. Multiple Sclerosis Journals 24(2):158–166. https://doi.org/10.1177/1352458517694090CrossRef

58.

Dörr J, Wernecke KD, Bock M, Gaede G, Wuerfel JT, Pfueller CF, Bellmann-Strobl J, Freing A, Brandt AU, Friedemann P (2011) Association of retinal and macular damage with brain atrophy in multiple sclerosis. PLoS ONE 6(4):e18132. https://doi.org/10.1371/journal.pone.0018132CrossRefPubMedCentralPubMed

59.

Pietroboni AM, Dell-Arti L, Caprioli M, Scarioni M, Carandini T, Arighi, A…Galimberti. (2019) The loss of macular ganglion cells begins from the early stages of disease and correlates with brain atrophy in multiple sclerosis patients. Mult Scler J 25(1):31–38. https://doi.org/10.1177/1352458517740214CrossRef

60.

Creel, D, Kolb, H, Fernandez, E, Nelson, R. 2012. Visually Evoked Potentials. Editors Webvision: The Organization of the Retina and Visual System. UT: University of Utah Health Sciences Center, Salt Lake City.

61.

Lebrun C, Bensa C, Debouverie M, Wiertlevski S, Brassat D, de Seze, J…Clavelou. (2009) Association between clinical conversion to multiple sclerosis in radiologically isolated syndrome and magnetic resonance imaging, cerebrospinal fluid, and visual evoked potential: Follow-up of 70 patients. Arch Neurol 66(7):841–846. https://doi.org/10.1001/archneurol.2009.119CrossRefPubMed

62.

Klistorner A, Triplett JD, Barnett MH, Yiannikas C, Barton J, Parratt, J…Stuart. (2021) Latency of multifocal visual evoked potential in multiple sclerosis: A visual pathway biomarker for clinical trials of remyelinating therapies. J Clin Neurophysiol 38(3):186–191. https://doi.org/10.1097/wnp.0000000000000757CrossRefPubMed

63.

Hegen H, Bsteh G, Berger T (2018) ‘No evidence of disease activity’ – is it an appropriate surrogate in multiple sclerosis? Eur J Neurol 25(9):1107-e101. https://doi.org/10.1111/ene.13669CrossRefPubMedCentralPubMed

64.

Cosima Oertel, F, Krämer, J, Motamedi, S, Keihani, A, Zimmermann, HG, Dimitriou, NG…Green. (2023). Visually evoked potential as prognostic biomarker for neuroaxonal damage in multiple sclerosis from a multicenter longitudinal cohort. Neurology: Neuroimmunology & Neuroinflammation, 10(3). https://doi.org/10.1212/NXI.0000000000200092

65.

Jindahra P, Petrie A, Plant GT (2009) Retrograde trans-synaptic retinal ganglion cell loss identified by optical coherence tomography. Brain 132:628–634. https://doi.org/10.1093/brain/awp001CrossRefPubMed

66.

Jindahra P, Petrie A, Plant GT (2012) The time course of retrograde trans-synaptic degeneration following occipital lobe damage in humans. Brain 135:534–541. https://doi.org/10.1093/brain/awr324CrossRefPubMed

Titel: Peering further into the mind’s eye: combining visual evoked potential and optical coherence tomography measures enhances insight into the variance in cognitive functioning in multiple sclerosis
verfasst von: Thomas J. Covey
Daniel Golan
Robert Sergott
Jeffrey Wilken
Myassar Zarif
Barbara Bumstead
MariJean Buhse
Olivia Kaczmarek
Glen M. Doniger
Iris-Katharina Penner
Laura M. Hancock
Hans Bogaardt
Marissa A. Barrera
Sarah A. Morrow
Steve Galetta
Mark Gudesblatt
Publikationsdatum: 13.12.2023
Verlag: Springer Berlin Heidelberg
Erschienen in: Journal of Neurology / Ausgabe 2/2024
Print ISSN: 0340-5354
Elektronische ISSN: 1432-1459
DOI: https://doi.org/10.1007/s00415-023-12075-5

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Neurologie

Schützt Olivenöl vor dem Tod durch Demenz?

10.05.2024 Morbus Alzheimer Nachrichten

Konsumieren Menschen täglich 7 Gramm Olivenöl, ist ihr Risiko, an einer Demenz zu sterben, um mehr als ein Vierten reduziert – und dies weitgehend unabhängig von ihrer sonstigen Ernährung. Dafür sprechen Auswertungen zweier großer US-Studien.

Bluttest erkennt Parkinson schon zehn Jahre vor der Diagnose

10.05.2024 Parkinson-Krankheit Nachrichten

Ein Bluttest kann abnorm aggregiertes Alpha-Synuclein bei einigen Menschen schon zehn Jahre vor Beginn der motorischen Parkinsonsymptome nachweisen. Mit einem solchen Test lassen sich möglicherweise Prodromalstadien erfassen und die Betroffenen früher behandeln.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Wartezeit nicht kürzer, aber Arbeit flexibler

Psychotherapie Medizin aktuell

Fünf Jahren nach der Neugestaltung der Psychotherapie-Richtlinie wurden jetzt die Effekte der vorgenommenen Änderungen ausgewertet. Das Hauptziel der Novellierung war eine kürzere Wartezeit auf Therapieplätze. Dieses Ziel wurde nicht erreicht, es gab jedoch positive Auswirkungen auf andere Bereiche.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Klimawandel und Gesundheit: Was Sie in der Hausarztpraxis wissen müssen und tun können

Springer Medizin

Abstract

Background

Objective

Results

Conclusion

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 2/2024

Differentiation of speech in Parkinson’s disease and spinocerebellar degeneration using deep neural networks

Neurosarcoidosis

Emotional burden among MS patients: associations between specific chronic pain diagnoses and psychological features

Case report of palatal tremor as a feature of CASPR2 autoimmune encephalitis

Transcriptomic analysis reveals associations of blood-based A-to-I editing with Parkinson’s disease